Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
| Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
|---|---|---|---|---|
| McFarlane EH et al. | 2000 | intact cell/cell culture, PC-12 cells (pheochromocytoma cell line from rat adrenal gland) | magnetic field, 50/60 Hz | 4.35–15.8 µT |
| Milani M et al. | 2001 | intact cell/cell culture, human lymphocytes | magnetic field, 50/60 Hz | 50 µT |
| Morabito C et al. | 2010 | intact cell/cell culture, PC-12 cells | magnetic field, low frequency, 50/60 Hz | 0.1–1 mT |
| Moraveji M et al. | 2021 | intact cell/cell culture, rat adipose-derived mesenchymal stem cells | magnetic field, 50/60 Hz, signals/pulses, also other exposures without EMF, co-exposure | - |
| Nafziger J et al. | 1997 | intact cell/cell culture, human bone marrow cells | magnetic field, 50/60 Hz | 10 µT–1 mT |
| Naghibzadeh M et al. | 2020 | intact cell/cell culture, human dermal fibroblasts | magnetic field, 50/60 Hz | 1–5 mT |
| Nurković J et al. | 2017 | - | magnetic field, 50/60 Hz, low frequency, also other exposures without EMF, co-exposure | - |
| Paradisi S et al. | 1993 | intact cell/cell culture, K562 cells (human erythroleukemic cell line) | magnetic field, 50/60 Hz | 2.5 mT |
| Pasi F et al. | 2016 | intact cell/cell culture, primary human dermal fibroblasts | magnetic field, 50/60 Hz, therapeutic/medical device | 0.25–1.6 mT |
| Picazo ML et al. | 1993 | animal, mouse/OF1, whole body | magnetic field, 50/60 Hz | 100 µT |
| Pozzi D et al. | 2007 | intact cell/cell culture, LAN-5 cells (human neuroblastoma cell line) | magnetic field, 50/60 Hz | 2 mT |
| Rageh MM et al. | 2012 | animal, rat/Wistar, whole body | magnetic field, low frequency, 50/60 Hz | 0.5 mT |
| Rajkovic V et al. | 2010 | animal, rat/Wistar, whole body | electric field, magnetic field, low frequency, 50/60 Hz, power transmission line | 100–300 µT |
| Raus Balind S et al. | 2016 | animal, rat/Wistar, whole body | magnetic field, 50/60 Hz | 0.5 mT |
| Rezaie-Tavirani M et al. | 2017 | intact cell/cell culture, SH-SY5Y (human neuroblastoma cell line) | magnetic field, 50/60 Hz | 0.5–1 mT |
| Rieti S et al. | 2004 | intact cell/cell culture, HaCaT cells (human keratinocytes cell line) | magnetic field, 50/60 Hz | 1 mT |
| Roushangar L et al. | 2007 | animal, rat/Wistar | magnetic field, 50/60 Hz | 3 mT |
| Saito A et al. | 2009 | intact cell/cell culture, P19 cells (mouse embryonal carcinoma cells) | magnetic field, low frequency, 50/60 Hz | 1–10 mT |
| Santini MT et al. | 2003 | intact cell/cell culture, human osteosarcoma cell lines (MG-63 and Saos-2) | magnetic field, 50/60 Hz | 500 µT |
| Santini MT et al. | 2006 | small, proliferating MG-63 spheroids | magnetic field, 50/60 Hz | 1 mT |
| Santoro N et al. | 1997 | intact cell/cell culture, Raji cells (human Burkitt lymphoma B lymphocyte cell line) | magnetic field, 50/60 Hz | 2 mT |
| Schmidt-Rohlfing B et al. | 2008 | intact cell/cell culture, chondrocytes (from human articular cartilage of osteoarthritic knee joints) | magnetic field, low frequency, signals/pulses, 50/60 Hz, electrotherapy | 2 mT |
| Sendera A et al. | 2024 | intact cell/cell culture, human adipose-derived mesenchymal stem cells | magnetic field, 50/60 Hz, low frequency | - |
| Shabani Z et al. | 2021 | animal, rat/ Wistar, whole body | magnetic field, 50/60 Hz, low frequency, also other exposures without EMF, co-exposure | 3 mT |
| Shoorche AB et al. | 2023 | intact cell/cell culture, MG-63 cells (human osteosarcoma cell line) | magnetic field, low frequency, 50/60 Hz, signals/pulses | - |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.
